Actively Recruiting

Phase 1
Age: 12Years - 75Years
All Genders
NCT07049575

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Led by Incyte Corporation · Updated on 2026-04-06

24

Participants Needed

24

Research Sites

57 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis suppurativa.

CONDITIONS

Official Title

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

Who Can Participate

Age: 12Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of hidradenitis suppurativa for at least 6 months before screening.
  • Diagnosis of hidradenitis suppurativa (Hurley Stage I, II, or III) with at least 4 abscesses and inflammatory nodules affecting 3 or more distinct anatomical areas at screening and Day 1.
  • Total estimated treatment body surface area greater than 20% at screening and baseline.
  • Agreement to avoid topical or systemic antibiotics for hidradenitis suppurativa during the treatment period.
  • Willingness to follow pregnancy prevention criteria as defined in the protocol.
  • Further inclusion criteria apply.
Not Eligible

You will not qualify if you...

  • Presence or history of other skin conditions that could affect evaluation of hidradenitis suppurativa.
  • Clinically uncontrolled cardiovascular disease, thrombosis, certain cancers, or infections.
  • Severe anemia, thrombocytopenia, or neutropenia.
  • Laboratory values outside protocol-defined ranges.
  • Other medical conditions as determined by the investigator.
  • Further exclusion criteria apply.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 24 locations

1

Saguaro Dermatology

Phoenix, Arizona, United States, 85008

Actively Recruiting

2

First Oc Dermatology

Fountain Valley, California, United States, 92708

Actively Recruiting

3

Amicis Research Center Valencia

Northridge, California, United States, 91324

Actively Recruiting

4

Children'S Hospital of Orange County

Orange, California, United States, 92868

Not Yet Recruiting

5

Clinical Trials Research Institute

Thousand Oaks, California, United States, 91320

Actively Recruiting

6

Clarity Dermatology

Castle Rock, Colorado, United States, 80109

Actively Recruiting

7

Advanced Pharma Cr, Llc

Miami, Florida, United States, 33147

Not Yet Recruiting

8

Advanced Pharma Cr, Llc

Miami, Florida, United States, 33147

Withdrawn

9

International Clinical Research Tennessee Llc

Sanford, Florida, United States, 32771

Actively Recruiting

10

Lenus Research Medical Group, Llc

Sweetwater, Florida, United States, 33172

Actively Recruiting

11

Trueblue Clinical Research

Tampa, Florida, United States, 33609

Actively Recruiting

12

Lane Dermatology and Dermatologic Surgery

Columbus, Georgia, United States, 31904

Actively Recruiting

13

Options Research Group, Llc

West Lafayette, Indiana, United States, 47906

Actively Recruiting

14

Equity Medical, Llc

Bowling Green, Kentucky, United States, 42104

Actively Recruiting

15

Delricht Research

Baton Rouge, Louisiana, United States, 70809

Actively Recruiting

16

Revival Research Institute, Llc Troy

Troy, Michigan, United States, 48084

Actively Recruiting

17

Red River Research Partners

Bolivar, Missouri, United States, 65613

Actively Recruiting

18

Dr Bobby Buka, Md Greenwich Village

New York, New York, United States, 10012-1354

Actively Recruiting

19

Equity Medical, Llc

New York, New York, United States, 10019

Actively Recruiting

20

Red River Research Partners

Fargo, North Dakota, United States, 58103

Actively Recruiting

21

Centricity Research Columbus

Columbus, Ohio, United States, 43213

Actively Recruiting

22

Unity Clinical Research

Oklahoma City, Oklahoma, United States, 73118

Actively Recruiting

23

Paddington Testing Co Inc

Philadelphia, Pennsylvania, United States, 19103

Actively Recruiting

24

Dermresearch, Inc.

Austin, Texas, United States, 78759

Withdrawn

Loading map...

Research Team

I

Incyte Corporation Call Center (US)

CONTACT

I

Incyte Corporation Call Center (ex-US)

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa | DecenTrialz